Newsroom

Press Releases

First ZAP-X Gyroscopic Radiosurgery Platform Installation in Poland

November 12, 2022

The Institut du Cancer Courlancy to Acquire ZAP-X Radiosurgery Platform

September 27, 2022

Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X

August 29, 2022

Chairman of Foxconn Technology Joins Board of Directors

June 30, 2022

ZAP CEO, Dr. John R. Adler, Receives Prestigious Janeway Medal

May 26, 2022

Baptist Health South Florida to Acquire ZAP-X

April 27, 2022

Renown French Oncology Research Group Selects ZAP Surgical Technology

March 12, 2022

Commissioner of Patents Rejects Elekta’s Request to Reverse 2021 Decision Invalidating Its Patent Claims

March 9, 2022

Announcing Strategic Partnership and Multi-System Order with Apollo Hospitals

March 1, 2022

Announcing the Installation of Pioneering Radiosurgery Platform at Japanese Bullet Train Station

February 1, 2022

Inspiring the Expansion of Novel Non-Invasive Brain Tumor Procedures

January 11, 2022

Industry Veterans to Lead Chinese Market Expansion

November 2, 2021

Bringing Next-Gen Non-Invasive Brain Tumor Treatment to France

October 27, 2021

Bringing the Latest Non-Invasive Brain Tumor Treatment to Madrid

August 30, 2021

Installing a New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

May 13, 2021

Upcoming: Installation of Novel Non-Invasive Brain Tumor Treatment System in Munich

April 21, 2021

U.S. Patent and Trademark Office Rules Elekta Patent Claims Invalid

April 6, 2021

Announcing First ZAP-X Gyroscopic Radiosurgery Platform Installation in Florida

March 2, 2021

Closing 2020 with 18 New System Orders

February 11, 2021

ZAP-X Gyroscopic Radiosurgery Platform Receives CE Mark Clearance

February 2, 2021

ZAP-X Gyroscopic Radiosurgery Platform Receives Japanese Shonin Approval

October 7, 2020

Spine Neurosurgeons: Expand your Practice with SRS

September 29, 2020

First Facility on the East Coast to Initiate Patient Treatment

September 22, 2020

Bringing World-Class Brain Tumor Treatments to Rural Germany

February 19, 2020

First ZAP-X Gyroscopic Radiosurgery Platform Installation in Poland

November 12, 2022

The Institut du Cancer Courlancy to Acquire ZAP-X Radiosurgery Platform

September 27, 2022

Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X

August 29, 2022

Chairman of Foxconn Technology Joins Board of Directors

June 30, 2022

ZAP CEO, Dr. John R. Adler, Receives Prestigious Janeway Medal

May 26, 2022

Baptist Health South Florida to Acquire ZAP-X

April 27, 2022

Renown French Oncology Research Group Selects ZAP Surgical Technology

March 12, 2022

Commissioner of Patents Rejects Elekta’s Request to Reverse 2021 Decision Invalidating Its Patent Claims

March 9, 2022

Announcing Strategic Partnership and Multi-System Order with Apollo Hospitals

March 1, 2022

Announcing the Installation of Pioneering Radiosurgery Platform at Japanese Bullet Train Station

February 1, 2022

Inspiring the Expansion of Novel Non-Invasive Brain Tumor Procedures

January 11, 2022

Industry Veterans to Lead Chinese Market Expansion

November 2, 2021

Bringing Next-Gen Non-Invasive Brain Tumor Treatment to France

October 27, 2021

Bringing the Latest Non-Invasive Brain Tumor Treatment to Madrid

August 30, 2021

Installing a New Gyroscopic Radiosurgery Platform for Treating Brain Tumors

May 13, 2021

Upcoming: Installation of Novel Non-Invasive Brain Tumor Treatment System in Munich

April 21, 2021

U.S. Patent and Trademark Office Rules Elekta Patent Claims Invalid

April 6, 2021

Announcing First ZAP-X Gyroscopic Radiosurgery Platform Installation in Florida

March 2, 2021

Closing 2020 with 18 New System Orders

February 11, 2021

ZAP-X Gyroscopic Radiosurgery Platform Receives CE Mark Clearance

February 2, 2021

ZAP-X Gyroscopic Radiosurgery Platform Receives Japanese Shonin Approval

October 7, 2020

Spine Neurosurgeons: Expand your Practice with SRS

September 29, 2020

First Facility on the East Coast to Initiate Patient Treatment

September 22, 2020

Bringing World-Class Brain Tumor Treatments to Rural Germany

February 19, 2020

Media Resources

Download photography, logos and resources for the media.

Media Contact

For additional questions contact:

Mark Arnold
Senior VP, Marketing

About ZAP

Our vision for the future of brain cancer and the team fighting to make it happen.